AMRUTANJAN HEALTH CARE
Back to Income Statement
|
AMRUTANJAN HEALTH CARE Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹452 Cr | ₹421 Cr | ₹380 Cr | ₹406 Cr | ₹333 Cr |
What is the latest Revenue of AMRUTANJAN HEALTH CARE ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹452 Cr |
| Mar2025 | ₹421 Cr |
| Mar2024 | ₹380 Cr |
| Mar2023 | ₹406 Cr |
| Mar2022 | ₹333 Cr |
How is Revenue of AMRUTANJAN HEALTH CARE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹452 Cr | 7.26 | |
| Mar2025 | ₹421 Cr | 10.96 | |
| Mar2024 | ₹380 Cr | -6.46 | |
| Mar2023 | ₹406 Cr | 21.93 | |
| Mar2022 | ₹333 Cr | - | |
Compare Revenue of peers of AMRUTANJAN HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMRUTANJAN HEALTH CARE | ₹1,417.1 Cr | -1.8% | -0.3% | -35.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
AMRUTANJAN HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMRUTANJAN HEALTH CARE | -1.8% |
-0.3% |
-35.4% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses